Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-06-10

FDA Approved: LOSARTAN POTASSIUM TABLETS, 25 MG — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Jubilant Cadista Pharmaceuticals Inc. to market Losartan potassium tablets, 25 mg, as a generic product under an ANDA supplemental approval. The ap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Losartan Potassium Tablets, 25 mg (LOSARTAN POTASSIUM)

Snippet

SUPPL AP for LOSARTAN POTASSIUM TABLETS, 25 MG (LOSARTAN POTASSIUM)